Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2006. Start Trial.
Date Value
October 02, 2026 0.5847
October 01, 2026 0.6022
September 30, 2026 0.6155
September 29, 2026 0.6221
September 28, 2026 0.6273
September 25, 2026 0.6249
September 24, 2026 0.6358
September 23, 2026 0.6495
September 22, 2026 0.651
September 21, 2026 0.6382
September 18, 2026 0.6453
September 17, 2026 0.6567
September 16, 2026 0.6552
September 15, 2026 0.6595
September 14, 2026 0.6628
September 11, 2026 0.6533
September 10, 2026 0.6647
September 09, 2026 0.6813
September 08, 2026 0.6746
September 04, 2026 0.6453
September 03, 2026 0.6491
September 02, 2026 0.6486
September 01, 2026 0.6555
August 31, 2026 0.6571
August 28, 2026 0.6614
Date Value
August 27, 2026 0.6661
August 26, 2026 0.6806
August 25, 2026 0.6699
August 24, 2026 0.6552
August 21, 2026 0.6671
August 20, 2026 0.6656
August 19, 2026 0.6808
August 18, 2026 0.669
August 17, 2026 0.6633
August 14, 2026 0.6661
August 13, 2026 0.6699
August 12, 2026 0.6656
August 11, 2026 0.6633
August 10, 2026 0.668
August 07, 2026 0.6798
August 06, 2026 0.6751
August 05, 2026 0.6822
August 04, 2026 0.6817
August 03, 2026 0.6694
July 31, 2026 0.6751
July 30, 2026 0.6737
July 29, 2026 0.6704
July 28, 2026 0.6604
July 27, 2026 0.6538
July 24, 2026 0.6415

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Neurocrine Biosciences, Inc. 3.938
Alkermes Plc 3.868
Liquidia Corp. 13.08
Akari Therapeutics Plc 0.8208
DBV Technologies SA 3.003

Price to Book Value Related Metrics

PS Ratio 1.385
Price to Free Cash Flow 16.55
Price 12.35
Earnings Yield -10.51%
Market Cap 259.38M